Description

The Sanadol line, developed in collaboration with the University of Naples Federico II, leverages the combination of CBD and CBG, two cannabinoids that reduce the perception of osteo-articular pain (the product’s effectiveness for neuropathic pain is currently under study), thanks to their anti-inflammatory action – particularly on CB1 and CB2 receptors and on TRPV channels (capsaicin channels that respond to the perception of “burning” pain, as with chili peppers). Added to this is the synergistic effect of Devil’s Claw extract (Harpagophytum procumbens), which – thanks to its high content of active glycosides – acts as a soothing agent for inflammation and slows the natural degradation of cartilage.
This product is also available in two strengths, unflavoured.